Organization
KK Women's and Children's Hospital
10 clinical trials
Clinical trial
Improving Sleep of Children With Neurodevelopmental Disorders: A Prospective, Randomised Controlled Trial Using Pulsed Current Stimulation Versus MelatoninStatus: Recruiting, Estimated PCD: 2024-03-31
Clinical trial
Comparison of Modified Programmed Intermittent Bolus (MPIB), Computer-integrated Patient Controlled Epidural Analgesia (CIPCEA) and Conventional Patient Controlled Epidural Analgesia (PCEA) During LabourStatus: Active (not recruiting), Estimated PCD: 2019-05-06
Clinical trial
The Administration of Saline Enema Versus Glycerin Suppository as a Treatment Intervention for Meconium Obstruction of Prematurity (MOP) and to Study the Impact on the Resolution of MOP, Time to Reach Full Enteral Feeds, Gut Microbiome, and Gut-brain Axis, a Randomised Control Trial.Status: Recruiting, Estimated PCD: 2026-07-31
Clinical trial
Vital Signs-Integrated Patient-Assisted Intravenous Opioid Analgesia for Post Surgical PainStatus: Active (not recruiting), Estimated PCD: 2023-12-31
Clinical trial
The Use of Letrozole or Mifepristone for Pretreatment of Medical Termination of Pregnancy: a Randomized, Non-inferiority TrialStatus: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
Vital-signs-integrated Patient-assisted Intravenous Opioid Analgesia for Postsurgical Pain: A Novel Modality to Improve Patient Safety by Detecting and Preventing Respiratory DepressionStatus: Active (not recruiting), Estimated PCD: 2017-05-30
Clinical trial
Comparison of the Role of Epidural Analgesia Versus Non-epidural Analgesia in Postnatal Depression and Persistent Pain Development: a Randomized Controlled TrialStatus: Active (not recruiting), Estimated PCD: 2021-07-19
Clinical trial
Development of Variable Volume Automated Mandatory Boluses (VVAMB) for Patient-controlled Epidural Analgesia During Labour and DeliveryStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility ProtocolStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage LeukaemiaStatus: Recruiting, Estimated PCD: 2024-12-01